How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?

Infiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type...

Full description

Bibliographic Details
Main Authors: Yoo Jin Lee, Yoo Ra Lee, Chung Gyo Seo, Hyun Gil Goh, Tae Hyung Kim, Sun Young Yim, Na Yeon Han, Jae Min Lee, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Hyonggin An, Beomjin Park, Yeon Seok Seo, Hyung Joon Yim, Ji Hoon Kim, Young Dong Yu, Dong Sik Kim, Yoon Tae Jeen, Hoon Jai Chun, Hong Sik Lee, Chang Duck Kim, Soon Ho Um
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/9/2589
id doaj-9a8717df3ce44b22ab149b878c0ca500
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yoo Jin Lee
Yoo Ra Lee
Chung Gyo Seo
Hyun Gil Goh
Tae Hyung Kim
Sun Young Yim
Na Yeon Han
Jae Min Lee
Hyuk Soon Choi
Eun Sun Kim
Bora Keum
Hyonggin An
Beomjin Park
Yeon Seok Seo
Hyung Joon Yim
Ji Hoon Kim
Young Dong Yu
Dong Sik Kim
Yoon Tae Jeen
Hoon Jai Chun
Hong Sik Lee
Chang Duck Kim
Soon Ho Um
spellingShingle Yoo Jin Lee
Yoo Ra Lee
Chung Gyo Seo
Hyun Gil Goh
Tae Hyung Kim
Sun Young Yim
Na Yeon Han
Jae Min Lee
Hyuk Soon Choi
Eun Sun Kim
Bora Keum
Hyonggin An
Beomjin Park
Yeon Seok Seo
Hyung Joon Yim
Ji Hoon Kim
Young Dong Yu
Dong Sik Kim
Yoon Tae Jeen
Hoon Jai Chun
Hong Sik Lee
Chang Duck Kim
Soon Ho Um
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
Cancers
hepatocellular carcinoma
AJCC 8th staging system
gross morphology
infiltrative type
nodular type
overall survival
author_facet Yoo Jin Lee
Yoo Ra Lee
Chung Gyo Seo
Hyun Gil Goh
Tae Hyung Kim
Sun Young Yim
Na Yeon Han
Jae Min Lee
Hyuk Soon Choi
Eun Sun Kim
Bora Keum
Hyonggin An
Beomjin Park
Yeon Seok Seo
Hyung Joon Yim
Ji Hoon Kim
Young Dong Yu
Dong Sik Kim
Yoon Tae Jeen
Hoon Jai Chun
Hong Sik Lee
Chang Duck Kim
Soon Ho Um
author_sort Yoo Jin Lee
title How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
title_short How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
title_full How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
title_fullStr How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
title_full_unstemmed How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
title_sort how should we assign large infiltrative hepatocellular carcinomas for staging?
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-09-01
description Infiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type HCC was assessed using the American Joint Committee on Cancer (AJCC) and Barcelona Clinic Liver Cancer (BCLC) staging systems. Seventy-four patients (9.6%) had infiltrative HCCs with a higher proportion of multifocal tumors, larger tumors, vessel invasion, increased tumor marker levels, and advanced T-stages than those with nodular HCC (all, <i>p</i><i> </i>< 0.01). Infiltrative morphology was independently associated with lower overall survival (OS), but its impact was significant when the tumor size was ≥ 4 cm (<i>p</i><i> </i>< 0.001). Under current AJCC and BCLC staging criteria, these large infiltrative HCCs were associated with significantly worse OS in early AJCC T-stages (T1b/T2, <i>p</i><i> </i>< 0.001) and BCLC stage A/B (both, p < 0.01) but not in late AJCC (T3/T4) and BCLC C. The reassignment of this subtype to T3 and T4 increased the discriminatory ability of AJCC T-staging with lower AIC values (3090 and 3088 vs. 3109) and higher c-index (0.69 and 0.69 vs. 0.67), respectively (both, p < 0.001). Similarly, the reassignment of large infiltrative HCC to BCLC stages B and C also improved the prognostic performance. Large infiltrative HCCs should be assigned to more advanced stages in current staging systems for their prognostic impact.
topic hepatocellular carcinoma
AJCC 8th staging system
gross morphology
infiltrative type
nodular type
overall survival
url https://www.mdpi.com/2072-6694/12/9/2589
work_keys_str_mv AT yoojinlee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT yooralee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT chunggyoseo howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hyungilgoh howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT taehyungkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT sunyoungyim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT nayeonhan howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT jaeminlee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hyuksoonchoi howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT eunsunkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT borakeum howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hyongginan howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT beomjinpark howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT yeonseokseo howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hyungjoonyim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT jihoonkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT youngdongyu howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT dongsikkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT yoontaejeen howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hoonjaichun howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT hongsiklee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT changduckkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
AT soonhoum howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging
_version_ 1724801771703894016
spelling doaj-9a8717df3ce44b22ab149b878c0ca5002020-11-25T02:36:02ZengMDPI AGCancers2072-66942020-09-01122589258910.3390/cancers12092589How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?Yoo Jin Lee0Yoo Ra Lee1Chung Gyo Seo2Hyun Gil Goh3Tae Hyung Kim4Sun Young Yim5Na Yeon Han6Jae Min Lee7Hyuk Soon Choi8Eun Sun Kim9Bora Keum10Hyonggin An11Beomjin Park12Yeon Seok Seo13Hyung Joon Yim14Ji Hoon Kim15Young Dong Yu16Dong Sik Kim17Yoon Tae Jeen18Hoon Jai Chun19Hong Sik Lee20Chang Duck Kim21Soon Ho Um22Department of Pathology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Radiology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Pathology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Biostatistics, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Radiology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Surgery, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Surgery, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaInfiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type HCC was assessed using the American Joint Committee on Cancer (AJCC) and Barcelona Clinic Liver Cancer (BCLC) staging systems. Seventy-four patients (9.6%) had infiltrative HCCs with a higher proportion of multifocal tumors, larger tumors, vessel invasion, increased tumor marker levels, and advanced T-stages than those with nodular HCC (all, <i>p</i><i> </i>< 0.01). Infiltrative morphology was independently associated with lower overall survival (OS), but its impact was significant when the tumor size was ≥ 4 cm (<i>p</i><i> </i>< 0.001). Under current AJCC and BCLC staging criteria, these large infiltrative HCCs were associated with significantly worse OS in early AJCC T-stages (T1b/T2, <i>p</i><i> </i>< 0.001) and BCLC stage A/B (both, p < 0.01) but not in late AJCC (T3/T4) and BCLC C. The reassignment of this subtype to T3 and T4 increased the discriminatory ability of AJCC T-staging with lower AIC values (3090 and 3088 vs. 3109) and higher c-index (0.69 and 0.69 vs. 0.67), respectively (both, p < 0.001). Similarly, the reassignment of large infiltrative HCC to BCLC stages B and C also improved the prognostic performance. Large infiltrative HCCs should be assigned to more advanced stages in current staging systems for their prognostic impact.https://www.mdpi.com/2072-6694/12/9/2589hepatocellular carcinomaAJCC 8th staging systemgross morphologyinfiltrative typenodular typeoverall survival